Literature DB >> 11574914

Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population.

M J Gonzales1, R N Machekano, R W Shafer.   

Abstract

Phylogenetic analysis of the reverse transcriptase (RT) and protease of 117 published complete human immunodeficiency virus (HIV) type 1 genome sequences demonstrated that these genes cluster into distinct subtypes. There was a slightly higher proportion of informative sites in the RT (40.4%) than in the protease (34.8%; P= .03). Although most variation between subtypes was due to synonymous nucleotide substitutions, several subtype-specific amino acid patterns were observed. In the protease, the subtype-specific variants included 7 positions associated with drug resistance. Variants at positions 10, 20, 36, and 82 were more common in non-B isolates, whereas variants at positions 63, 77, and 93 were more common in subtype B isolates. In the RT, the subtype-specific mutations did not include positions associated with anti-retroviral drug resistance. RT and protease sequences from 2246 HIV-infected persons in northern California were also examined: 99.4% of the sequences clustered with subtype B, whereas 0.6% clustered with subtype A, C, or D.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11574914      PMCID: PMC2597357          DOI: 10.1086/323601

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  Virtually full-length subtype F and F/D recombinant HIV-1 from Africa and South America.

Authors:  T Laukkanen; J K Carr; W Janssens; K Liitsola; D Gotte; F E McCutchan; E Op de Coul; M Cornelissen; L Heyndrickx; G van der Groen; M O Salminen
Journal:  Virology       Date:  2000-03-30       Impact factor: 3.616

2.  Sequence and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe.

Authors:  R W Shafer; T K Chuang; P Hsu; C B White; D A Katzenstein
Journal:  AIDS Res Hum Retroviruses       Date:  1999-01-01       Impact factor: 2.205

3.  Impact of HIV type 1 subtype variation on viral RNA quantitation.

Authors:  B Parekh; S Phillips; T C Granade; J Baggs; D J Hu; R Respess
Journal:  AIDS Res Hum Retroviruses       Date:  1999-01-20       Impact factor: 2.205

4.  Genetic variation and susceptibilities to protease inhibitors among subtype B and F isolates in Brazil.

Authors:  A Tanuri; A C Vicente; K Otsuki; C A Ramos; O C Ferreira; M Schechter; L M Janini; D Pieniazek; M A Rayfield
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

5.  Most HIV-1 genetic subtypes have entered Sweden.

Authors:  A Alaeus; T Leitner; K Lidman; J Albert
Journal:  AIDS       Date:  1997-02       Impact factor: 4.177

6.  Approximate methods for estimating the pattern of nucleotide substitution and the variation of substitution rates among sites.

Authors:  Z Yang; S Kumar
Journal:  Mol Biol Evol       Date:  1996-05       Impact factor: 16.240

7.  Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning.

Authors:  M O Salminen; J K Carr; D S Burke; F E McCutchan
Journal:  AIDS Res Hum Retroviruses       Date:  1995-11       Impact factor: 2.205

8.  Polymorphism of the human immunodeficiency virus type 1 (HIV-1) protease gene and response of HIV-1-infected patients to a protease inhibitor.

Authors:  P Bossi; M Mouroux; A Yvon; F Bricaire; H Agut; J M Huraux; C Katlama; V Calvez
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

9.  Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease.

Authors:  S Ganeshan; R E Dickover; B T Korber; Y J Bryson; S M Wolinsky
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

10.  Identification of a clinical isolate of HIV-1 with an isoleucine at position 82 of the protease which retains susceptibility to protease inhibitors.

Authors:  R W King; D L Winslow; S Garber; H T Scarnati; L Bachelor; S Stack; M J Otto
Journal:  Antiviral Res       Date:  1995-09       Impact factor: 5.970

View more
  27 in total

1.  Reverse transcriptase and protease sequence evolution in two HIV-1-infected couples.

Authors:  Sarah Palmer; Dominique Vuitton; Matthew J Gonzales; Agnés Bassignot; Robert W Shafer
Journal:  J Acquir Immune Defic Syndr       Date:  2002-11-01       Impact factor: 3.731

2.  HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms.

Authors:  Jaideep Ravela; Bradley J Betts; Francoise Brun-Vézinet; Anne-Mieke Vandamme; Diane Descamps; Kristel van Laethem; Kate Smith; Jonathan M Schapiro; Dean L Winslow; Caroline Reid; Robert W Shafer
Journal:  J Acquir Immune Defic Syndr       Date:  2003-05-01       Impact factor: 3.731

3.  Protease and reverse transcriptase mutation patterns in HIV type 1 isolates from heavily treated persons: comparison of isolates from Northern California with isolates from other regions.

Authors:  Matthew J Gonzales; Ilana Belitskaya; Kathryn M Dupnik; Soo-Yon Rhee; Robert W Shafer
Journal:  AIDS Res Hum Retroviruses       Date:  2003-10       Impact factor: 2.205

4.  HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy.

Authors:  Rami Kantor; Lynn S Zijenah; Robert W Shafer; Solomon Mutetwa; Elizabeth Johnston; Robert Lloyd; Andrea von Lieven; Dennis Israelski; David A Katzenstein
Journal:  AIDS Res Hum Retroviruses       Date:  2002-12-10       Impact factor: 2.205

Review 5.  HIV sequence databases.

Authors:  Carla Kuiken; Bette Korber; Robert W Shafer
Journal:  AIDS Rev       Date:  2003 Jan-Mar       Impact factor: 2.500

6.  A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.

Authors:  Robert W Shafer; Kathryn Dupnik; Mark A Winters; Susan H Eshleman
Journal:  HIV Seq Compend       Date:  2001

Review 7.  Drug resistance and antiretroviral drug development.

Authors:  Robert W Shafer; Jonathan M Schapiro
Journal:  J Antimicrob Chemother       Date:  2005-04-21       Impact factor: 5.790

8.  Use of sequence data generated in the Bayer Tru Gene genotyping assay to recognize and characterize non-subtype-b human immunodeficiency virus type 1 strains.

Authors:  Diane L Hirigoyen; Charles P Cartwright
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

9.  Web resources for HIV type 1 genotypic-resistance test interpretation.

Authors:  Tommy F Liu; Robert W Shafer
Journal:  Clin Infect Dis       Date:  2006-04-28       Impact factor: 9.079

10.  Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation.

Authors:  Matthew J Gonzales; Eric Delwart; Soo-Yon Rhee; Rose Tsui; Andrew R Zolopa; Jonathan Taylor; Robert W Shafer
Journal:  J Infect Dis       Date:  2003-07-10       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.